CHRN

ChronoScale Corporation
NASDAQTECHNOLOGYINFORMATION TECHNOLOGY SERVICES

Key Statistics

Market Cap
$2.63B
P/E Ratio
EPS
$-0.51
Beta
0.99
52W High
$28.20
52W Low
$2.91
50-Day MA
$17.35
200-Day MA
$9.97
Dividend Yield
Profit Margin
-86.20%
Forward P/E
PEG Ratio

About ChronoScale Corporation

ChronoScale Corporation (Ticker: CHRN) is an innovative biotechnology firm committed to advancing healthcare through the development and commercialization of groundbreaking therapeutics targeted at unmet medical needs. With a strong pipeline bolstered by strategic partnerships and a focus on leveraging cutting-edge technology, CHRN is poised to make significant contributions to patient care and drive advancements in the industry. Its dedication to scientific rigor and excellence positions the company to capitalize on emerging opportunities within the fast-evolving healthcare sector, establishing itself as a key player in the biotechnology landscape.

Official WebsiteUSAFY End: May

Fundamentals

Revenue (TTM)$84.38M
Gross Profit (TTM)$-7.13M
EBITDA$24.91M
Operating Margin-39.40%
Return on Equity0.00%
Return on Assets0.00%
Revenue/Share (TTM)$0.00
Book Value$27.64
Price-to-Book23.96
Price-to-Sales (TTM)31.20
EV/Revenue29.96
EV/EBITDA99.82
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$145.22M
Float81,670
% Insiders97.57%
% Institutions1.16%

Historical Volatility

HV 10-Day
152.86%
HV 20-Day
135.53%
HV 30-Day
157.94%
HV 60-Day
125.26%
HV Rank

Volatility is currently contracting

Latest News

ChronoScale Appoints Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to Accelerate Global AI Infrastructure Strategy

DALLAS, June 04, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ: CHRN) (“ChronoScale” or the “Company”), an accelerated compute platform purpose-built to support demanding artificial intelligence workloads, today announced the appointments of Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer. The appointments strengthen ChronoScale's executive leadership team as the Company expands its AI infrastructure platform and accelerates delivery of large-scale compute solutions for enterprises, hyperscalers, and AI innovators worldwide.

GlobeNewsWire6/4/2026Neutral

More TECHNOLOGY Stocks

Data last updated: 7/9/2026